A new approach to the treatment of metastatic paraganglioma: sorafenib.

about

Primary Pulmonary Paraganglioma: A Case Report and Review of Literature Pulmonary and mediastinal paragangliomas: rare endothoracic malignancies with challenging diagnosis and treatment

P2860

Q26801124-A872549D-75BE-48F0-8F1F-0A2BF5FC3FFD Q58771059-3BCE2D9D-A008-40CB-AC11-EA85EF9C5E21

P2860

A new approach to the treatment of metastatic paraganglioma: sorafenib.

Item

http://www.wikidata.org/entity/Q54337099

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

A new approach to the treatment of metastatic paraganglioma: sorafenib.

@en

A new approach to the treatment of metastatic paraganglioma: sorafenib.

@nl

type

Item

label

A new approach to the treatment of metastatic paraganglioma: sorafenib.

@en

A new approach to the treatment of metastatic paraganglioma: sorafenib.

@nl

prefLabel

A new approach to the treatment of metastatic paraganglioma: sorafenib.

@en

A new approach to the treatment of metastatic paraganglioma: sorafenib.

@nl

P1476

A new approach to the treatment of metastatic paraganglioma: sorafenib.

@en

P2093

Arbil Avci

http://www.w3.org/2001/XMLSchema#string

Berna Bozkurt Duman

http://www.w3.org/2001/XMLSchema#string

Ismail Oguz Kara

http://www.w3.org/2001/XMLSchema#string

Melek Ergin

http://www.w3.org/2001/XMLSchema#string

Meral Gunaldi

http://www.w3.org/2001/XMLSchema#string

P2860

Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas

Laparoscopic surgery for malignant adrenal tumors

Metastatic paraganglioma.

Malignant pheochromocytoma.

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).

Clinical spectrum and outcome of functional extraadrenal paraganglioma.

Metastatic paraganglioma and treatment with sunitinib: a case report.

Sunitinib, a novel therapy for anthracycline- and cisplatin-refractory malignant pheochromocytoma.

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.

Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.

P304

411-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4143/CRT.2013.093

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Çiğdem Usul Afşar

P577

2014-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264053834

http://www.w3.org/2001/XMLSchema#string

P698

25036577

http://www.w3.org/2001/XMLSchema#string

P932

4206070

http://www.w3.org/2001/XMLSchema#string

A new approach to the treatment of metastatic paraganglioma: sorafenib.

about

P2860

P2860

A new approach to the treatment of metastatic paraganglioma: sorafenib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932